Hallucinogen abuse, in remission
ICD-10 F16.11 is a billable code used to indicate a diagnosis of hallucinogen abuse, in remission.
Hallucinogen abuse, in remission, refers to a condition where an individual has a history of hallucinogen use disorder but is currently not experiencing any symptoms of substance use or withdrawal. Hallucinogens, such as LSD, psilocybin, and mescaline, can lead to significant psychological dependence and alterations in perception, mood, and cognitive processes. The diagnosis of 'in remission' indicates that the individual has not engaged in hallucinogen use for a specified period, typically at least 12 months, and is not exhibiting any related symptoms. This status is crucial for treatment planning and monitoring, as individuals in remission may still face challenges related to cravings or psychological triggers. Treatment often involves counseling, support groups, and behavioral therapies aimed at maintaining sobriety and addressing underlying mental health issues. Clinicians must document the duration of remission and any ongoing treatment or support mechanisms in place to ensure accurate coding and appropriate care.
Detailed history of substance use, treatment plans, and progress notes on remission status.
Patients transitioning from active use to remission, requiring ongoing support and monitoring.
Consideration of co-occurring disorders and the need for integrated treatment approaches.
Comprehensive mental health evaluations, including assessments of substance use history and current mental status.
Patients with a history of hallucinogen use presenting with anxiety or mood disorders.
Documentation of any therapeutic interventions aimed at preventing relapse.
Used for patients in therapy for hallucinogen abuse.
Progress notes detailing the patient's history and treatment plan.
Addiction specialists should document the focus on substance use and recovery.
In remission indicates that the individual has not used hallucinogens for a specified period, typically at least 12 months, and is not experiencing any withdrawal symptoms or related issues.
